Analysts see substantial growth potential for Tarsus Pharmac...
Analysts see substantial growth potential for Tarsus Pharmaceuticals, raising revenue forecasts despite higher expected losses per share. Bullish sentiment persists amid mixed financial adjustments.
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Have Been Lifting Their Price Targets
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4531Followers
0Following
9921Visitors
Follow